Translated version of this PSD: Arabic
The provision of a senior loan of up to USD 2.5 million to finance the expansion of MedLabs Consultancy Group into the West Bank through establishing ten new branches in eight different cities of the West Bank.
Financing of the expansion of a well-established Jordanian diagnostics company in the West Bank.
The range of services to be offered by MedLabs in the West Bank will provide high quality lab services in areas where it is still much needed. As the public sector faces challenges to sustain the capital funding for necessary diagnostic services, the authorities involve the private sector as part of an integrated public healthcare system. The EBRD will therefore play an important role in helping the company expand into the West Bank market, which is in need to develop its healthcare services through private sector participation.
By opening ten new branches of high-quality laboratories in the West Bank, the Project will lead to higher penetration rates of modern healthcare services, mainly in urban centers. The Project will also contribute to increasing the FDI inflow in the healthcare sector in the West Bank, which have been limited in the last years.
MEDLABS CONSULTANCY GROUP
MedLabs Consultancy Group is a Jordanian company founded in 1993 in Amman which provides services in the field of laboratory medicine. Over the last 25 years, MedLabs has become the region's fastest growing network of private stand-alone and hospital-based medical laboratories employing more than 400 employees. The Company has 42 branches in Jordan and also operates in Iraq. It has state of the art facilities and has been recognized by many international and local accreditations.
EBRD Finance Summary
Total Project Cost
Environmental and Social Summary
Categorised B (2014 ESP) Environmental and social issues associated with the development of 10 medical laboratories in West Bank by the Jordanian medical laboratory operator are likely to be site specific and can be addressed by implementation of the internationally acknowledged medical laboratory quality management standards. Environmental and social due diligence (ESDD) has been carried out by ESD confirmed that the Company has laboratory quality management accreditations and will continue to apply them for the new laboratories. Premises for the new laboratories will be either purchased or rented, and there will be no greenfield construction involved. An Environmental and Social Action Plan (ESAP) is currently under development to address an employee grievance mechanism of the Company and continued laboratory quality and environmental, health & safety management by application of the international accreditations. The Company is required that the project complies with EBRD PRs as well as IFC's environmental, health and safety guidelines for health care facilities and provides an annual environmental and social report to the Bank.
The ESDD comprised of the reviews of the completed Environmental and Social Questionnaire, documentation provided by the Company (e.g. OSH procedure, chemical substance handling procedures, waste management procedure, emergency plan, and patient right statement) as well as follow up communication with the Company. The ESDD showed that the Company has international accreditations from the College of American Pathologists (CAP) and is in compliance with ISO 9001:2008 quality management as well as the European ISO 151189 Laboratory Accreditation. The new 10 labs to be opened in 3 years will also have CAP, ISO 9001, and ISO 151189 accreditations at each laboratory level. Every two years a third party audit takes place at the laboratories to renew the accreditations. Medical waste for the new laboratories will be collected by a licensed waste management company in the same way as that of the existing laboratories. Each new laboratory is expected to recruited five or six licenced medical technicians.
While the Company has formal HR procedures for the existing 367 employees (e.g. remediation policy, working time and overtime policy and non-discrimination and equal opportunity in employment policy, etc.), it is currently improving the existing employee grievance mechanism. As stated above, the ESAP will address the grievance mechanism as well as ensure that the new laboratories will have adequate environmental, health and safety risk management procedures in accordance with the international accreditations, EBRD PRs and IFC environmental, health and safety guidelines for health care facilities. The project will be monitored through the review of annual E&S reports and monitoring site visits, if deemed necessary.
Company Contact Information
Dr. Hassib Sahyoun
Zahran Street, Amman, 11183, Jordan P.O. Box 830200
For business opportunities or procurement, contact the client company.
EBRD project enquiries not related to procurement:
Tel: +44 20 7338 7168
Public Information Policy (PIP)
The PIP sets out how the EBRD discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations. Please visit the Public Information Policy page below to find out how to request a Public Sector Board Report.
Text of the PIP
Project Complaint Mechanism (PCM)
The Project Complaint Mechanism (PCM) is the EBRD's accountability mechanism. It provides an opportunity for an independent review of complaints from individuals and organisations concerning EBRD-financed projects which are alleged to have caused, or are likely to cause, environmental and/or social harm.
Please visit the Project Complaint Mechanism page to find information about how to submit a complaint. The PCM Officer (firstname.lastname@example.org) is available to answer any questions you may have regarding the submission of a complaint and criteria for registration and eligibility, in accordance with the PCM Rules of Procedure.